Integrin αIIbβ3: from discovery to efficacious therapeutic target

K Bledzka, SS Smyth, EF Plow - Circulation research, 2013 - Am Heart Assoc
From the initial description of platelets in 1882, their propensity to aggregate and to
contribute to thrombosis was apparent. Indeed, excessive platelet aggregation is associated …

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction

PG Chassot, A Delabays… - British Journal of …, 2007 - academic.oup.com
Recent clinical data show that the risk of coronary thrombosis after antiplatelet drugs
withdrawal is much higher than that of surgical bleeding if they are continued. In secondary …

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug–drug interaction

WC Lau, LA Waskell, PB Watkins, CJ Neer… - Circulation, 2003 - Am Heart Assoc
Background—We observed that the prodrug clopidogrel was less effective in inhibiting
platelet aggregation with coadministration of atorvastatin during point-of-care platelet …

[HTML][HTML] Integrin targeted therapeutics

M Millard, S Odde, N Neamati - Theranostics, 2011 - ncbi.nlm.nih.gov
Integrins are heterodimeric, transmembrane receptors that function as mechanosensors,
adhesion molecules and signal transduction platforms in a multitude of biological processes …

Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis

VB Lê, JG Schneider, Y Boergeling, F Berri… - American journal of …, 2015 - atsjournals.org
Rationale: The hallmark of severe influenza virus infection is excessive inflammation of the
lungs. Platelets are activated during influenza, but their role in influenza virus pathogenesis …

Evolution of in silico strategies for protein-protein interaction drug discovery

SJY Macalino, S Basith, NAB Clavio, H Chang, S Kang… - Molecules, 2018 - mdpi.com
The advent of advanced molecular modeling software, big data analytics, and high-speed
processing units has led to the exponential evolution of modern drug discovery and better …

LMO1 synergizes with MYCN to promote neuroblastoma initiation and metastasis

S Zhu, X Zhang, N Weichert-Leahey, Z Dong, C Zhang… - Cancer cell, 2017 - cell.com
A genome-wide association study identified LMO1, which encodes an LIM-domain-only
transcriptional cofactor, as a neuroblastoma susceptibility gene that functions as an …

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations

S Harder, U Klinkhardt, JM Alvarez - Clinical pharmacokinetics, 2004 - Springer
Perioperative management of chronically anticoagulated patients and/or patients treated
with antiplatelet therapy is a complex medical problem. This review considers the …

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non‐ST segment elevation acute coronary …

X Bosch, J Marrugat, J Sanchis - Cochrane Database of …, 2013 - cochranelibrary.com
Background During percutaneous coronary intervention (PCI), and in non‐ST segment
elevation acute coronary syndromes (NSTEACS), the risk of acute vessel occlusion by …

Modeling HIV-1 induced neuroinflammation in mice: role of platelets in mediating blood-brain barrier dysfunction

LD Jones, JW Jackson, SB Maggirwar - PLoS One, 2016 - journals.plos.org
The number of HIV-1 positive individuals developing some form of HIV-associated
neurocognitive disorder (HAND) is increasing. In these individuals, the integrity of the blood …